BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 9508738)

  • 1. Limitations of the toxic equivalency factor approach for risk assessment of TCDD and related compounds.
    Safe S
    Teratog Carcinog Mutagen; 1997-1998; 17(4-5):285-304. PubMed ID: 9508738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development validation and problems with the toxic equivalency factor approach for risk assessment of dioxins and related compounds.
    Safe SH
    J Anim Sci; 1998 Jan; 76(1):134-41. PubMed ID: 9464894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polychlorinated biphenyls (PCBs): environmental impact, biochemical and toxic responses, and implications for risk assessment.
    Safe SH
    Crit Rev Toxicol; 1994; 24(2):87-149. PubMed ID: 8037844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicology and carcinogenesis studies of a mixture of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (Cas No. 1746-01-6), 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) (Cas No. 57117-31-4), and 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) in female Harlan Sprague-Dawley rats (gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Sep; (526):1-180. PubMed ID: 17342195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of bioassays and approaches for the risk assessment of 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds.
    Safe S
    Environ Health Perspect; 1993 Oct; 101 Suppl 3(Suppl 3):317-25. PubMed ID: 8143638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of polychlorinated dibenzo-p-dioxin, dibenzofuran, and biphenyl congeners for producing rainbow trout early life stage mortality.
    Zabel EW; Walker MK; Hornung MW; Clayton MK; Peterson RE
    Toxicol Appl Pharmacol; 1995 Oct; 134(2):204-13. PubMed ID: 7570596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicology and carcinogenesis studies of a binary mixture of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) and 2,3',4,4',5-pentachlorobiphenyl (PCB 118) (Cas No. 31508-00-6) in female Harlan Sprague-Dawley rats (gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Nov; (531):1-218. PubMed ID: 17342196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developing tools for risk assessment in protected species: Relative potencies inferred from competitive binding of halogenated aromatic hydrocarbons to aryl hydrocarbon receptors from beluga (Delphinapterus leucas) and mouse.
    Jensen BA; Reddy CM; Nelson RK; Hahn ME
    Aquat Toxicol; 2010 Nov; 100(3):238-45. PubMed ID: 20728228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Approach to risk assessment of PCDDs and PCDFs in Canada.
    Feeley MM; Grant DL
    Regul Toxicol Pharmacol; 1993 Dec; 18(3):428-37. PubMed ID: 8128004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NTP technical report on the toxicology and carcinogenesis studies of 2,2',4,4',5,5'-hexachlorobiphenyl (PCB 153) (CAS No. 35065-27-1) in female Harlan Sprague-Dawley rats (Gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 May; (529):4-168. PubMed ID: 16835634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk assessments of polychlorinated dibenzo- p-dioxins, polychlorinated dibenzofurans, and dioxin-like polychlorinated biphenyls in food.
    Larsen JC
    Mol Nutr Food Res; 2006 Oct; 50(10):885-96. PubMed ID: 17009211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative potency based on hepatic enzyme induction predicts immunosuppressive effects of a mixture of PCDDS/PCDFS and PCBS.
    Smialowicz RJ; DeVito MJ; Williams WC; Birnbaum LS
    Toxicol Appl Pharmacol; 2008 Mar; 227(3):477-84. PubMed ID: 18190939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consensus toxicity factors for polychlorinated dibenzo-p-dioxins, dibenzofurans, and biphenyls combining in silico models and extensive in vitro screening of AhR-mediated effects in human and rodent cells.
    Larsson M; van den Berg M; Brenerová P; van Duursen MB; van Ede KI; Lohr C; Luecke-Johansson S; Machala M; Neser S; Pěnčíková K; Poellinger L; Schrenk D; Strapáčová S; Vondráček J; Andersson PL
    Chem Res Toxicol; 2015 Apr; 28(4):641-50. PubMed ID: 25654323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential relative effect potencies of some dioxin-like compounds in human peripheral blood lymphocytes and murine splenic cells.
    van Ede KI; Gaisch KP; van den Berg M; van Duursen MB
    Toxicol Lett; 2014 Apr; 226(1):43-52. PubMed ID: 24472611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exposure and effects assessment of resident mink (Mustela vison) exposed to polychlorinated dibenzofurans and other dioxin-like compounds in the Tittabawassee River basin, Midland, Michigan, USA.
    Zwiernik MJ; Kay DP; Moore J; Beckett KJ; Khim JS; Newsted JL; Roark SA; Giesy JP
    Environ Toxicol Chem; 2008 Oct; 27(10):2076-87. PubMed ID: 18435568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polychlorinated biphenyls (PCBs), dibenzo-p-dioxins (PCDDs), dibenzofurans (PCDFs), and related compounds: environmental and mechanistic considerations which support the development of toxic equivalency factors (TEFs).
    Safe S
    Crit Rev Toxicol; 1990; 21(1):51-88. PubMed ID: 2124811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of postnatal exposure to mixtures of non-ortho-PCBs, PCDDs, and PCDFs in prepubertal female rats.
    Desaulniers D; Leingartner K; Musicki B; Yagminas A; Xiao GH; Cole J; Marro L; Charbonneau M; Tsang BK
    Toxicol Sci; 2003 Oct; 75(2):468-80. PubMed ID: 12883090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of cardiotoxicity mediated by halogenated aromatic hydrocarbons to aryl hydrocarbon receptor activation.
    Heid SE; Walker MK; Swanson HI
    Toxicol Sci; 2001 May; 61(1):187-96. PubMed ID: 11294989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative contributions of affinity and intrinsic efficacy to aryl hydrocarbon receptor ligand potency.
    Hestermann EV; Stegeman JJ; Hahn ME
    Toxicol Appl Pharmacol; 2000 Oct; 168(2):160-72. PubMed ID: 11032772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.